Anesthesia Medical News about FDG

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effects of food intake and anesthetic on cardiac imaging and uptake of BMS747158-02 in comparison with FDG
Journal of Nuclear Cardiology, 06/29/09

Yu M et al. - Unlike FDG, BMS747158-02 cardiac images are clear and not affected by the feeding state and anesthetics.

Exclusive Author Commentary
Ming Yu, 07/06/09

BMS747158-02 is an 18F labeled agent being developed for myocardial perfusion imaging (MPI) with positron emission tomography (PET). Cardiac imaging with this agent shows clear myocardium and identification of the perfusion deficit area in rats, rabbits, pigs, nonhuman primates and human subjects. In isolated heart preparation, myocardial extraction of this agent is higher and correlates better with flow at a wide range of flow rates than currently available SPECT MPI agents. In a recent pig study, the myocardial perfusion measured by PET imaging with BMS747158-02 correlated well with flow quantified by microsphere technique both at rest and stress conditions. These findings suggest that BMS747158-02 possesses an improved chemical profile with less “roll-off” phenomena observed with the current SPECT MPI agents. In this study, impacts of feeding state and anesthetic on cardiac imaging and uptake of this agent were examined in rats in comparison with 18F-fluorodeoxyglucose (FDG). Results showed heart uptake of FDG was low and heart was not visible when imaged with FDG in rats fasted or anesthetized with ketamine and xylazine. However, unlike FDG, heart upatke of BMS747158-02 was high under these conditions. Cardiac images of this agent are clear and not affected by the feeding state and anesthetics.

<< Previous
Is reflex sympathetic dystrophy/complex regional pain syndrome...

Next >>
Factors contributing to large analgesic effects in placebo...

Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09 Relevance Score: 91%

Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
European Journal of Radiology, 10/26/09 Relevance Score: 91%

Incidental Detection of Granulomatous Prostatitis by F-18 FDG PET/CT in a Patient with Bladder Cancer: A Rare Complication of BCG Instillation Therapy
Clinical Nuclear Medicine, 10/07/09 Relevance Score: 89%

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma
European Journal of Nuclear Medicine & Molecular Imaging, 10/13/09 Relevance Score: 87%

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to evaluate response after Iodine-131 MIBG therapy for relapsed neuroblastoma
Journal of Clinical Oncology, 10/09/09 Relevance Score: 87%